Company Profile
Atara Biotherapeutics, Inc. Stock Price, News & Analysis
- Ticker:
- ATRA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Atara Biotherapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
11.16 USD (+5.18%)
Close
Last updated: June 23, 2026 at 00:00
100.55M USD
Market cap
Why the stock is moving
ATRA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Atara Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Atara Biotherapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Atara Biotherapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Atara Biotherapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational Progress
Source: Atara Biotherapeutics, Inc.
- 02
Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel®)
Source: Atara Biotherapeutics, Inc.
- 03
- 04
Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress
Source: Atara Biotherapeutics, Inc.
- 05
Atara Biotherapeutics Announces Changes to Its Board of Directors
Source: Atara Biotherapeutics, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Atara Biotherapeutics, Inc. (ATRA)?
Atara Biotherapeutics, Inc. (ATRA) most recently closed at 11.16 USD, a +5.18% move versus the previous session.
What is the market cap of Atara Biotherapeutics, Inc. (ATRA)?
Atara Biotherapeutics, Inc. currently has a market capitalization of 100.55M USD on BioPharmSignal.
What does Atara Biotherapeutics, Inc. do?
Atara Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ATRA stock listed?
Atara Biotherapeutics, Inc. (ATRA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Atara Biotherapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Atara?
Atara Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Atara Biotherapeutics, Inc. targeting with Atara?
Atara Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biotherapeutics?
Atara Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.